多个hERG通道阻断途径:对宏分子的影响
1Institute of Pharmacology, Toxicology and Clinical Pharmacy, Technische Universität Braunschweig, Mendelssohnstr. 1, 38106 Braunschweig, Germany.
Trends in pharmacological sciences
|July 23, 2024
概括
许多药物可以通过阻断人类以太-to-go-go相关基因 (hERG) 通道引起危险的心律不整. 本综述探讨了生物药物如何在不寻常的部位抑制hERG通道,从而构成torsadogenic风险.
科学领域:
- 药理学 药理学是指药理学的学科.
- 心脏电生理学 心脏电生理学
- 药品安全 药品安全
背景情况:
- 非心血管性药物可以通过阻断人类以太-to-go-go相关基因 (hERG) 通道引起torsades de pointes (TdP).
- hERG通道阻塞剂通常通过它们与通道内腔的相互作用来识别.
- 据认为,由于膜扩散差,生物制剂的hERG抑制风险较低.
研究的目的:
- 审查hERG通道上的生物制品潜在的非正规结合点.
- 评估宏分子治疗药物的托萨多基因潜力.
- 提供非传统hERG通道阻塞器的概述.
主要方法:
- 关于hERG通道阻断剂的现有研究的文献综述.
- 对生物制剂提出的非正规结合机制的分析.
- 讨论对药物安全性评估的影响.
主要成果:
- 生物制剂可能通过非正规的结合点抑制hERG通道,而不依赖孔隙接入.
- 这种相互作用仍然可能导致TdP心律失常.
- 对宏分子疗法的评估需要考虑这些替代抑制机制.
结论:
- 生物制剂对hERG通道抑制的风险需要重新评估.
- 非正规的结合部位代表了巨分子药物TdP诱导的潜在机制.
- 目前的药物安全范式可能需要更新,以包括这些发现.
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.2K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.2K
Ligand-gated Ion Channels
12.4K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.4K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Multi-pass Transmembrane Proteins and β-barrels
5.2K
In multi-pass transmembrane proteins, the polypeptide chain crosses the membrane more than once. The transmembrane polypeptide chain either forms an α-helix or β-strand structure. α-Helix containing multi-pass transmembrane proteins are ubiquitous, whereas β-strand containing ones are mainly found in gram-negative bacteria, mitochondria, and chloroplasts.
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as...
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as...
5.2K
Targets for Drug Action: Overview
6.1K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.1K
G-Protein Gated Ion Channels
4.6K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.6K


